ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

M.D. Anderson Breast Cancer Studies Promising NEJM Publishes Bonadnna Report

February 27, 1976

ACS Prostate Cancer Screening Guideline Urges Doctor-Patient Informed Decision

March 5, 2010

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

NCI Cooperative Group, Cancer Center Trials Listed

November 25, 2005

Prevention & Control Study Section Needed: Letter to the Editor

June 11, 1993